Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
14
Number of overlapping holdings
16.5%
% of SBIO's 90 holdings also in IBRN
35.0%
% of IBRN's 58 holdings also in SBIO
Overlap by Weight
Sector Drift (SBIO minus IBRN)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in SBIO |
Weight in IBRN |
Overlap | |
|---|---|---|---|---|
 |
ALKERMES PLC | 4.1% | 3.9% | 3.9% |
 |
PTC THERAPEUTICS INC | 3.6% | 4.5% | 3.6% |
|
ACADIA PHARMACEUTICALS INC | 2.3% | 4.2% | 2.3% |
|
DENALI THERAPEUTICS INC. | 1.9% | 3.8% | 1.9% |
|
EDGEWISE THERAPEUTICS, INC. | 1.2% | 2.3% | 1.2% |
Position Highlights (Non-Overlapping Exposures)
SBIO Overweight Relative to IBRN
|
AXSOME THERAPEUTICS, INC. | 4.4% |
|
RHYTHM PHARMACEUTICALS, INC. | 3.8% |
|
AVIDITY BIOSCIENCES INC | 3.1% |
 |
ZAI LAB LTD. UNSPONSORED ADR | 2.9% |
 |
MERUS N.V. | 2.9% |
|
AKERO THERAPEUTICS, INC. | 2.9% |
|
PROTAGONIST THERAPEUTICS, INC. | 2.8% |
|
CRINETICS PHARMACEUTICALS INC | 2.7% |
 |
MOONLAKE IMMUNOTHERAPEUTICS CLASS A | 2.4% |
|
AMICUS THERAPEUTICS INC | 2.0% |
SBIO Underweight Relative to IBRN
|
CATALYST PHARMACEUTICAL PART | -5.1% |
 |
ARGENX SE ADR | -5.0% |
 |
SK BIOPHARMACEUTICALS CO., LTD. | -5.0% |
|
NEUROCRINE BIOSCIENCES INC | -4.5% |
|
SCHOLAR ROCK HOLDING CORP. | -4.3% |
|
SUPERNUS PHARMACEUTICALS INC | -4.2% |
|
BIOGEN IDEC INC | -3.9% |
|
INTEGRA LIFESCIENCES HOLDING | -2.7% |
|
SAREPTA THERAPEUTICS INC | -2.6% |
 |
SANBIO CO., LTD. | -2.1% |